Duality Advisers’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-90,881
| Closed | -$1.71M | – | 499 |
|
|
2023
Q1 | $1.71M | Buy |
90,881
+6,216
| +7% | +$117K | 0.19% | 191 |
|
|
2022
Q4 | $1.35M | Sell |
84,665
-27,574
| -25% | -$439K | 0.15% | 238 |
|
|
2022
Q3 | $1.84M | Sell |
112,239
-100,855
| -47% | -$1.65M | 0.2% | 199 |
|
|
2022
Q2 | $3M | Buy |
213,094
+190,976
| +863% | +$2.69M | 0.3% | 102 |
|
|
2022
Q1 | $536K | Buy |
+22,118
| New | +$536K | 0.06% | 458 |
|
|
2021
Q4 | – | Sell |
-132,205
| Closed | -$2.2M | – | 468 |
|
|
2021
Q3 | $2.2M | Buy |
132,205
+121,596
| +1,146% | +$2.02M | 0.17% | 233 |
|
|
2021
Q2 | $259K | Sell |
10,609
-5,732
| -35% | -$140K | 0.02% | 491 |
|
|
2021
Q1 | $422K | Sell |
16,341
-12,297
| -43% | -$318K | 0.04% | 462 |
|
|
2020
Q4 | $1.53M | Buy |
+28,638
| New | +$1.53M | 0.11% | 267 |
|